Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 15 2024 - 4:01PM
Journey Medical Corporation (“Journey Medical” or “the Company”)
(Nasdaq: DERM), a commercial-stage pharmaceutical company that
primarily focuses on the selling and marketing of U.S. Food and
Drug Administration (“FDA”)-approved prescription pharmaceutical
products for the treatment of dermatological conditions, announced
today that Claude Maraoui, Co-Founder, President and Chief
Executive Officer, will participate in a fireside chat at the
Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company
Showcase on Tuesday, May 21, 2024, at 1:00 p.m. ET.
Please click here to register for the
conference.
A replay of the fireside chat will be available
shortly after the conference on the News and Events page of the
Investors section of Journey Medical’s website,
www.journeymedicalcorp.com, for approximately 30 days after the
meeting.
About Journey Medical
CorporationJourney Medical Corporation (Nasdaq: DERM)
(“Journey Medical”) is a commercial-stage pharmaceutical company
that primarily focuses on the selling and marketing of FDA-approved
prescription pharmaceutical products for the treatment of
dermatological conditions through its efficient sales and marketing
model. The Company currently markets seven branded and two generic
products that help treat and heal common skin conditions. The
Journey Medical team comprises industry experts with extensive
experience in developing and commercializing some of dermatology’s
most successful prescription brands. Journey Medical is located in
Scottsdale, Arizona and was founded by Fortress Biotech, Inc.
(Nasdaq: FBIO). Journey Medical’s common stock is registered under
the Securities Exchange Act of 1934, as amended, and it files
periodic reports with the U.S. Securities and Exchange Commission
(“SEC”). For additional information about Journey Medical, visit
www.journeymedicalcorp.com.
Company Contact:Jaclyn Jaffe(781)
652-4500ir@jmcderm.com
Media Relations Contact:Tony Plohoros6
Degrees(908)
591-2839tplohoros@6degreespr.com
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Aug 2023 to Aug 2024